DK0807627T3 - Anilidforbindelser som ACAT-inhibitorer - Google Patents

Anilidforbindelser som ACAT-inhibitorer

Info

Publication number
DK0807627T3
DK0807627T3 DK97108154T DK97108154T DK0807627T3 DK 0807627 T3 DK0807627 T3 DK 0807627T3 DK 97108154 T DK97108154 T DK 97108154T DK 97108154 T DK97108154 T DK 97108154T DK 0807627 T3 DK0807627 T3 DK 0807627T3
Authority
DK
Denmark
Prior art keywords
compounds
group
oxygen
optionally
pharmaceutical compositions
Prior art date
Application number
DK97108154T
Other languages
Danish (da)
English (en)
Inventor
Katsumi Kawamine
Yukihiro Sato
Toshiyuki Edano
Kimiyuki Shibuya
Souhei Tanabe
Masami Shiratsuchi
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Application granted granted Critical
Publication of DK0807627T3 publication Critical patent/DK0807627T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/70Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
DK97108154T 1996-05-17 1997-05-20 Anilidforbindelser som ACAT-inhibitorer DK0807627T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15874396 1996-05-17
JP08866097A JP4191269B2 (ja) 1996-05-17 1997-03-25 新規なアニリド化合物及びこれを含有する医薬

Publications (1)

Publication Number Publication Date
DK0807627T3 true DK0807627T3 (da) 2006-04-10

Family

ID=26430018

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97108154T DK0807627T3 (da) 1996-05-17 1997-05-20 Anilidforbindelser som ACAT-inhibitorer

Country Status (7)

Country Link
US (2) US6204278B1 (fr)
EP (1) EP0807627B1 (fr)
JP (1) JP4191269B2 (fr)
AT (1) ATE314352T1 (fr)
DE (1) DE69734952T2 (fr)
DK (1) DK0807627T3 (fr)
ES (1) ES2252765T3 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1020451B1 (fr) * 1997-03-25 2005-06-15 Kowa Co., Ltd. Composes anilide et medicaments les contenant
EP0987254B1 (fr) * 1997-05-26 2004-12-22 Kowa Co., Ltd. Nouveaux composes de diamine cycliques et medicament contenant ces composes
US6969711B2 (en) 1997-05-26 2005-11-29 Kowa Company, Ltd. Cyclic diamine compounds and medicine containing the same
JP4402176B2 (ja) * 1997-11-14 2010-01-20 興和株式会社 新規アミド化合物及びこれを含有する医薬
US6849647B1 (en) 1999-07-21 2005-02-01 Kowa Company, Ltd. Amide compounds and medications containing the same technical field
JP4592130B2 (ja) * 1999-08-05 2010-12-01 大塚化学株式会社 チオ酢酸アミド化合物及び農園芸用殺菌剤
US6622484B2 (en) 2001-02-02 2003-09-23 Caterpillar Inc. Hystat/split torque modulation
JP4242765B2 (ja) * 2001-08-22 2009-03-25 興和株式会社 血管壁選択的なacat阻害剤
US7163944B2 (en) * 2004-01-26 2007-01-16 Kowa Co., Ltd. Cyclic diamine compound and pharmaceutical containing the same
EP1809759B1 (fr) 2004-10-06 2013-09-11 The Brigham And Women's Hospital, Inc. Pertinence de niveaux obtenus de marqueurs d'inflammation generalisee ala suite d'un traitement
US8633233B2 (en) 2008-08-06 2014-01-21 Hydra Biosciences, Inc. Methods and compositions for treating anxiety
JP5523993B2 (ja) 2010-08-31 2014-06-18 富士フイルム株式会社 酸ハロゲン化物の製造方法、及び酸ハロゲン化物
PT2970303T (pt) 2013-03-15 2017-06-23 Hydra Biosciences Inc Xantinas substituídas e métodos de sua utilização
WO2025194116A1 (fr) * 2024-03-15 2025-09-18 The Regents Of The University Of California Inhibiteurs de pcsk9 et leurs utilisations

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB921791A (en) * 1960-01-21 1963-03-27 Ici Ltd New dyestuffs
US3720686A (en) 1971-04-01 1973-03-13 Squibb & Sons Inc Mercaptobenzimidazole derivatives
DE2903966A1 (de) 1979-02-02 1980-08-07 Bayer Ag Substituierte carbonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als herbizide
EP0005501B1 (fr) * 1978-05-20 1981-11-25 Bayer Ag Heteroaryloxy-acetamides, procédé pour leur préparation et leur utilisation comme herbicides
SE460667B (sv) 1979-09-20 1989-11-06 Nippon Chemiphar Co Cyklohexankarboxylsyraderivat, foerfarande foer framstaellning daerav samt naemnda derivat foer terapeutisk anvaendning
GB2093835B (en) 1981-01-22 1984-10-31 Nippon Chemiphar Co Novel guanidinocyclohexanecarboxylic acid derivatives and a process for producing the same
DE3419994A1 (de) * 1984-05-29 1985-12-05 Hoechst Ag, 6230 Frankfurt Benzoxazolyl- und benzthiazolyl-aminosaeuren, ihre herstellung und verwendung im pflanzenschutz
CA2003283A1 (fr) 1988-12-05 1990-06-05 C. Anne Higley Imidazoles pour le traitement de l'atherosclerose
WO1991004027A1 (fr) 1989-09-15 1991-04-04 Pfizer Inc. Nouveaux derives de n-aryle de n-heteroarylamide et d'uree en tant qu'inhibiteurs d'acyl coenzyme a: cholesterol acyl transferase
US5668136A (en) 1990-09-25 1997-09-16 Eisai Co., Ltd. Trisubstituted benzene derivatives, composition and methods of treatment
JPH04139172A (ja) * 1990-10-01 1992-05-13 Sankyo Co Ltd α―スルフィニル置換アセトアミド誘導体
US5362878A (en) 1991-03-21 1994-11-08 Pfizer Inc. Intermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT)
US5364875A (en) 1992-05-11 1994-11-15 The Du Pont Merck Pharmaceutical Company Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis
US5290801A (en) * 1992-05-29 1994-03-01 The Du Pont Merck Pharmaceutical Company Benzimidazoles for the treatment of atherosclerosis
WO1998035957A1 (fr) * 1997-02-14 1998-08-20 Bayer Corporation Derives amides actifs comme antagonistes selectifs du recepteur du neuropeptide y

Also Published As

Publication number Publication date
US6204278B1 (en) 2001-03-20
JP4191269B2 (ja) 2008-12-03
JPH1029986A (ja) 1998-02-03
EP0807627A3 (fr) 1997-12-03
ES2252765T3 (es) 2006-05-16
EP0807627B1 (fr) 2005-12-28
EP0807627A2 (fr) 1997-11-19
DE69734952D1 (de) 2006-02-02
ATE314352T1 (de) 2006-01-15
US6825223B2 (en) 2004-11-30
DE69734952T2 (de) 2006-07-27
US20020037910A1 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
DK1424330T3 (da) Aktivator for peroxisom proliferator-responsiv receptor delta
PT987254E (pt) Compostos de diamina ciclica, originais, e medicamentos que os contem
DK0807627T3 (da) Anilidforbindelser som ACAT-inhibitorer
IL120266A (en) Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
DK0842661T3 (da) Anvendelse af estrogenagonister og -antagonister til fremstilling af et lægemiddel til behandling af atherosclerose, uafhængigt af lipidsænkning
FI920271A0 (fi) Polyamintioler som straolningsskyddande aemnen.
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
FI971227A0 (fi) Pyramidinyylipyratsolijohdannaisia
DE60223904D1 (de) Benzylaminanalogen
ATE372320T1 (de) Cyclische amidderivate
EP1306369A4 (fr) Nouveaux composes sulfures et composes intermoleculaires renfermant lesdits composes comme composant
SE8303913D0 (sv) Heterocykliska foreningar
AU6517698A (en) Novel anilide compounds and drugs containing the same